Bronchial asthma in children
Conditions
Interventions
Lung solid and kidney deficient group:Zi su jiang qi decoction Chinese herbal formula granules
Healthy control group:none
Phlegm-heat obstructing the lung group:Ma Xing Shi Gan Decoction combined with Su Ting Pill Chinese herbal formula granules
Group of external cold and internal heat:Big Qinglong Decoction Chinese herbal formula granules
Wind-cold confinement to the lung group:Medicinal formula granule for dispelling wind and eliminating phlegm
Sponsors
Shenzhen Children's Hospital Futian District Shenzhen City Guangdong Province
Eligibility
Sex/Gender
All
Age
5 Years to 14 Years
Inclusion criteria
Inclusion criteria: It conforms to the Western medicine diagnostic criteria for bronchial asthma in children. It conforms to the diagnostic criteria of traditional Chinese medicine for the syndromes of wind-cold constricting the lung phlegm-heat obstructing the lung external cold and internal heat and lung solid and kidney deficiency. Children aged 5-14 years old who come to the clinic. With the consent of the child's legal guardian who can cooperate with treatment and sampling and with the guardian signing the informed consent form. The patient had not received any other treatment before entering the study. Inclusion criteria for the healthy control group: Healthy children in the same area as the experimental group. There is no blood relationship with the experimental group no asthma and pulmonary diseases. Children aged 5-14. The informed consent of the child's legal guardian must be obtained and signed.
Exclusion criteria
Exclusion criteria: Anyone who does not meet the inclusion criteria. Children with wheezing diseases caused by cardiogenic asthma congenital cardiovascular disease congenital airway malformation and inhalation of tracheal foreign body. Children with other primary diseases such as cardiovascular and cerebrovascular liver and kidney and hematopoietic system diseases as well as mental and nervous system diseases; Or children with immunodeficiency function. Children whose legal guardians do not agree to cooperate with treatment and sampling and children whose clinical information is incomplete. Those who have allergic reactions to the drugs used in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main symptom scoring; | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy index;Sub-symptom score; | — |
Countries
China
Contacts
Public ContactWanlisheng
Shenzhen Children's Hospital
Outcome results
None listed